Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma

Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive neoplasm with a poor outcome. Novel L-asparaginase-based treatment regimens, such as GELOX (gemcitabine, oxaliplatin, and L-asparaginase) and P-gemox (gemcitabine, oxaliplatin, and pegaspargase), have shown promising results against...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Wang, Jing-hua, Wang, Hua, Wang, Yan-jun, Xia, Zhong-jun, Huang, Hui-qiang, Jiang, Wen-qi, Lu, Yue
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Clinical Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085239/
https://ncbi.nlm.nih.gov/pubmed/27072578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8643
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki